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Abstract The initiation of translation on eukaryotic mRNA is
governed by the concerted action of polypeptides of the eIF-4F
complex. One of these polypeptides, eIF-4G, is proteolytically
inactivated upon infection with several members of the Picorna-
viridae family. This cleavage occurs by the action of virus-
encoded proteinases: 2Apro (entero- and rhinovirus) or Lpro
(aphthovirus). An indirect mode of eIF-4G cleavage through the
activation of a second cellular proteinase has been proposed in
the case of poliovirus. Although cleavage of eIF-4G by rhino- and
coxsackievirus 2Apro has been achieved directly in vitro, a
similar activity has not been documented to date for poliovirus
2Apro. We report here that a recombinant form of poliovirus
2Apro fused to maltose binding protein (MBP) directly cleaves
human eIF-4G from a highly purified eIF-4F complex. Efficient
cleavage of eIF-4G requires magnesium ions. The presence of
other initiation factors such as eIF-3, eIF-4A or eIF-4B mimics
in part the stimulatory effect of magnesium ions and probably
stabilizes the cleavage products of eIF-4G generated by 2Apro.
These results suggest that efficient cleavage of eIF-4G by MBP-
2Apro requires a proper conformation of this factor. Finally,
MBP-2Apro protein cleaves an eIF-4G-derived synthetic peptide
at the same site as rhino- and coxsackievirus 2Apro (R485-
G486).
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1. Introduction
Translation of eukaryotic mRNAs requires the concerted
action of the initiation complex 4F (eIF-4F), together with
other components that participate in the initiation event.
The eIF-4F complex recognizes the cap structure present at
the 5P end of mRNAs, unwinds the secondary structure of the
leader sequence and promotes the binding of mRNAs to ri-
bosomes [1^3]. Mammalian eIF-4F has been puri¢ed as a
complex of three polypeptides: eIF-4E (24 kDa, cap-binding
protein), eIF-4A (50 kDa, RNA helicase) and eIF-4G (220
kDa) [4,5]. The eIF-4F complex interacts with other initiation
factors, such as eIF-3 and eIF-4B to promote the entry of the
small 40S ribosomal subunit to the mRNA [6^9].
Host translation is rapidly halted upon infection of suscep-
tible cells with poliovirus as well as with other members of the
Picornaviridae family. In the case of entero-, rhino-, and aph-
thovirus genera, shut-o¡ of translation has been related to the
functional inactivation of the eIF-4F complex. Indeed, soon
after infection of susceptible cells with these viruses, eIF-4G
(220 kDa) is cleaved giving rise to an amino-terminal frag-
ment of 13 kDa and to a carboxy fragment of 100 kDa
[10,7,11,12]. Both genetic and biochemical evidence supports
the notion that virus-encoded proteinases 2Apro (Lpro in aph-
thovirus) are responsible for the proteolytic bissection of eIF-
4G [13^15]. However, the molecular details of the proteolytic
process of eIF-4G are still very much debated. For poliovirus
2Apro, a model of indirect cleavage through the activation of a
quiescent cellular proteinase has been proposed [16,17]. This
latent cellular proteinase would be, in the last instance, that
responsible for eIF-4G cleavage following a cascade mecha-
nism triggered by poliovirus 2Apro. This model was proposed
on the basis of early observations where poliovirus 2Apro did
not copurify with eIF-4G cleavage activity obtained from po-
liovirus-infected HeLa extracts [18]. Moreover, extracts from
E. coli obtained expressing poliovirus 2Apro require a cellular
component to mediate cleavage of a partially puri¢ed eIF-4G
[16]. This putative cellular proteinase was initially identi¢ed as
initiation factor eIF-3. Further work resolved the putative
protease from eIF-3 that was reidenti¢ed as a protein of 55^
60 kDa unrelated to eIF-3 [17]. However, the role of these two
cellular factors in 2Apro-mediated cleavage of eIF-4G remains
uncertain.
In contrast, direct cleavage of eIF-4G has been achieved
using recombinant rhino- and coxsackievirus 2Apro and puri-
¢ed eIF-4F complex obtained from rabbit reticulocytes
[19,20]. More recently, eIF-4G assembled into the 4F complex
has been proposed as the natural substrate for rhinovirus
2Apro, suggesting that the conformational state of eIF-4G
when bound to the other eIF-4F subunits determines its sus-
ceptibility to be cleaved by picornaviral 2A proteinases [21].
Strikingly, such an activity has not been analyzed for polio-
virus 2Apro, perhaps due to the di⁄culty to obtain this pro-
teinase in an active form. Recently, we have puri¢ed a re-
combinant and active form of poliovirus 2Apro fused to
maltose binding protein (MBP). In the present work, we ex-
amine if this recombinant poliovirus 2Apro is able to cleave
directly the eIF-4G subunit from the eIF-4F complex.
2. Materials and methods
2.1. Puri¢cation of initiation factors from HeLa cells
eIF-4F complex used as substrate in cleavage experiments was pu-
ri¢ed from the ribosomal salt wash (RSW) of HeLa S3 cells as de-
scribed previously [22]. Brie£y, RSW was precipitated with 40% am-
monium persulfate and the resulting pellet was resuspended and
dialyzed against H100 bu¡er (20 mM HEPES (pH 7.5), 100 mM
KCl, 2 mM EDTA, 5% glycerol, 10 mM L-mercaptoethanol and
1 Wg/ml aprotinin). This extract, enriched in eIF-4F and eIF-3 factors,
was further puri¢ed by two chromatographic steps. First, a 7m-GTP-
Sepharose column (Pharmacia) was used to retain the eIF-4F com-
plex. Bound proteins were eluted in H100 bu¡er plus 7m-GTP and
fractions containing eIF-4F (monitored by Western blotting against
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the eIF-4G subunit) were pooled and loaded on a Mono Q 5/5 col-
umn (Pharmacia) that had been equilibrated with bu¡er H100. eIF-4F
complex was eluted at approximately 360 mM KCl and dialyzed
against bu¡er H100. The degree of eIF-4F puri¢cation was deter-
mined by silver staining of gels and by Western blotting using antisera
against eIF-4G, eIF-4A, eIF-4E and eIF-3 factors. Puri¢ed eIF-3,
eIF-4A and eIF-4B were obtained from HeLa cells as described pre-
viously [6].
2.2. Puri¢cation of MBP-2Apro
Poliovirus 2Apro was puri¢ed as fusion protein with MBP (maltose
binding protein) following the instructions recommended by the man-
ufacturer (New England Biolabs). After binding of MBP-2Apro ex-
pressing bacterial extracts to the amylose column, the fusion protein
was eluted in bu¡er MBP (10 mM HEPES (pH 7.4), 50 mM KCl,
2 mM DTT, 5% glycerol and 10 mM maltose). The resulting fractions
contained homogeneously pure MBP-2Apro at 0.5 Wg/ml. MBP protein
alone was puri¢ed in parallel.
2.3. Cleavage experiment of eIF-4G
Cleavage reactions were carried out in bu¡er MBP (without mal-
tose) in a ¢nal volume of 15 Wl, containing 100 ng of puri¢ed eIF-4F
and the indicated amounts of MBP-2Apro. The reactions were incu-
bated at 30‡C for 75 min and stopped by addition of sample bu¡er
(62 mM Tris-HCl (pH 6.8), 2% SDS, 0.1 M DTT, 17% glycerol and
0.024% bromophenol blue), boiled for 5 min and analyzed by SDS-
PAGE and Western blotting. When indicated, reactions were supple-
mented with 5 mM Mg(AcO)2. In some cases, puri¢ed initiation fac-
tors eIF-3, 4A or 4B obtained from Hela cells were added to the
reactions and incubated for 5 min prior to the addition of MBP-2Apro.
2.4. Electrophoresis and Western blotting
Usually, proteins were separated on a 7.5%-acrylamide gel (SDS-
PAGE), transferred to nitrocellulose membrane and blotted against
the indicated antisera as described previously [10]. A mixture of rabbit
antisera generated against synthetic peptides from the amino-terminus
and carboxy-terminus of eIF-4G was used.
2.5. Synthesis and analysis of peptides
Peptide 4G (GRTTLSTRGPPRGG) encompassing amino acids
478^491 of human eIF-4G was synthesized by a peptide synthesizer
apparatus (Applied Biosystems, model 431A) using the Fmoc proce-
dure. Cleavage products generated after incubation of peptide 4G
with MBP-2Apro were separated by reverse HPLC and the molecular
weight veri¢ed by plasma desorption mass spectroscopy.
3. Results
3.1. Puri¢cation of human eIF-4F complex
To address whether or not poliovirus 2Apro cleaves directly
eIF-4G factor, eIF-4F complex was ¢rst puri¢ed from HeLa
cells as described previously [22]. The puri¢ed fractions con-
tained equimolar amounts of eIF-4G (220 kDa) and eIF-4E
(24 kDa), but lacked eIF-4A polypeptide (50 kDa) (data not
shown). This composition of eIF-4F was not surprising, be-
cause eIF-4A may copurify or not with eIF-4F depending on
the ionic strength of the bu¡ers and the type of column em-
ployed [22].
Wycko¡ et al. [16] provided evidence that eIF-3 is required
for poliovirus 2Apro-mediated cleavage of eIF-4G. Therefore,
we ¢rst tested if our preparation of eIF-4F contained eIF-3
factor. To this end, eIF-4F preparations were probed with an
antiserum against human eIF-3. This factor, with an esti-
mated molecular weight of 550 kDa, is composed of 10 sub-
units [23]. As shown in Fig. 1, even at the highest concentra-
tion of eIF-4F, no apparent bands of eIF-3 subunits are
detected. Longer exposures of the immunoblot did not reveal
any band relative to eIF-3 (result not shown). Antiserum
raised against eIF-3 reacts weakly with eIF-4F (220 kDa) as
described previously [6]. Therefore, our preparation of eIF-4F
is essentially free of eIF-3.
3.2. Cleavage of eIF-4G by MBP-2Apro
Lamphear et al. [19] reported that recombinant 2Apro from
rhino- and coxsackievirus directly cleaved puri¢ed eIF-4F
from rabbit reticulocyte. Under these conditions, addition of
puri¢ed eIF-3 did not enhance eIF-4G cleavage. Since 2Apro
proteinases from polio-, rhino- and coxsackieviruses share a
substantial degree of sequence homology (more than 60%), it
is unlikely that these proteinases follow di¡erent mechanisms
to cleave the same cellular factor, i.e. eIF-4G. To address this
possibility, recombinant poliovirus 2Apro was puri¢ed from E.
coli as a fusion protein with MBP (MBP-2Apro) as described
[24]. Preliminary experiments showed that this recombinant
proteinase cleaves eIF-4G factor from HeLa S10 extracts.
Moreover, we have observed that cleavage of eIF-4G by
MBP-2Apro is inhibited by low concentrations of sodium
ions (results not shown). This result agrees with those ob-
tained by [25], but contrasts with those reported for rhinovi-
rus 2Apro, where optimal proteinase activity is reached at 150^
250 mM NaCl [26]. Therefore, potassium ions were included
in all bu¡ers instead of sodium ions.
Addition of 2 Wg of MBP-2Apro to eIF-4F preparation in
the presence of 5 mM Mg (AcO)2 results in an almost com-
plete cleavage of eIF-4G (Fig. 2A, lane 4). Under these con-
ditions, addition of puri¢ed eIF-3 or eIF-4A does not exert
any e¡ect on this cleavage (Fig. 2A, lanes 7 and 8). Parallel
incubations of eIF-4F with 2 Wg of control protein MBP does
not a¡ect the integrity of eIF-4G (Fig. 2A, lane 3), strongly
suggesting that cleavage of this factor is a speci¢c property of
poliovirus 2Apro. Interestingly, the cleavage products derived
from eIF-4G upon treatment with MBP-2Apro, especially the
carboxy-terminus, are poorly detected by the anti-eIF-4G
antibodies as compared with those originated after treatment
of HeLa RSW with MBP-2Apro. The reason of this observa-
tion is unclear, but it can be explained by the instability of the
carboxy-terminal fragment of eIF-4G leading to its further
cleavage. Interestingly, a similar observation has been re-
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Fig. 1. Puri¢ed eIF-4F is free of eIF-3 factor. The indicated
amounts of puri¢ed eIF-4F factor obtained from HeLa cells were
analyzed by Western blotting using an antiserum against eIF-4F
(left panel) or an antiserum against human eIF-3 (right panel). Lane
denoted as eIF-3 contains 80 ng of puri¢ed human eIF-3. The
bands corresponding to eIF-4G and ¢ve of the 10 subunits of eIF3
factor (p170, p115, p105, p66 and p47) are indicated.
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ported recently using both recombinant rhinovirus 2Apro and
human eIF-4G [21].
In the absence of magnesium ions eIF-4G is poorly cleaved
by MBP-2Apro (Fig. 2A, lane 12). Under these conditions,
only 10^20% of eIF-4F is bissected by poliovirus 2Apro, sug-
gesting that magnesium ions play a key role to make eIF-4G
accessible to MBP-2Apro. The addition of eIF-3, eIF-4A or
eIF-4B separately to the reaction does not exert any e¡ect on
eIF-4G proteolysis. However, simultaneous addition of the
three initiation factors to the reaction considerably enhances
eIF-4G cleavage (Fig. 2A, lane 16). Moreover, the eIF-4G
fragments generated under these conditions are more easily
detected with the anti-eIF-4G antibodies. Therefore, addition
of this set of initiation factors to the cleavage reaction mimics,
at least in part, the e¡ect observed with magnesium ions.
Interestingly, Lamphear et al. [9] have recently mapped the
regions of the interaction of eIF-3 and eIF-4A with eIF-4G.
The amino-terminal moiety of eIF-4G interacts with eIF-4E,
while the carboxy-terminus binds eIF-3 and eIF-4A. Possibly
magnesium ions as well as the interaction of these factors with
eIF-4G could hold eIF-4G in a conformation accessible to the
enzymatic attack of MBP-2Apro. In addition, the interaction
of eIF-3 and eIF-4A with the carboxy-terminal fragment of
eIF-4G upon MBP-2Apro cleavage could protect this fragment
from further degradation. This is consistent with the fact that
the cleavage products of eIF-4G are stable in poliovirus-in-
fected cells [27].
3.3. Cleavage of an eIF-4G-derived synthetic peptide by
MBP-2Apro
To get further insight into the direct cleavage mechanism of
eIF-4G by poliovirus 2Apro, we tested the activity of MBP-
2Apro on a synthetic peptide matching the cleavage site
mapped on human eIF-4G for rhino- and coxsackievirus
2Apro [19]. Thus, a 14-mer peptide encompassing the amino
acid sequence from 478 to 491 of eIF-4G was synthesized [12].
This peptide was incubated with MBP-2Apro either in the
presence or absence of magnesium ions and cleavage products
were analyzed by HPLC. As shown in Fig. 3, the parent
peptide dissappears and a novel product with a lower reten-
tion time on the HPLC column is obtained upon incubation
with MBP-2Apro. Data from plasma desorption mass spec-
trometry unambiguously probed that the peptide product cor-
responds to the sequence GRTTLSTR, which results from a
single cleavage of the parent peptide at its ¢rst Arg-Gly bond.
The second digestion product (GPPRGG) is not observed in
the chromatogram, most probably because this short peptide
eluates in the ¢rst fractions with DTT and ions. Addition of
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Fig. 2. Cleavage of eIF-4G factor by MBP-2Apro. In£uence of magnesium ions and several eukaryotic initiation factors. A: Reactions contain-
ing 100 ng of puri¢ed eIF-4F and 2 Wg of MBP-2Apro were incubated in the presence (left panel) or absence (right panel) of 5 mM Mg(AcO)2
for 75 min at 30‡C. Where indicated, 400 ng of eIF-3, 250 ng of eIF-4B or 250 ng of eIF-4A were added to the reaction mixture 5 min prior
to the addition of MBP-2Apro. 30 Wg of ribosomal salt wash (RSW) from HeLa cells were incubated with or without MBP-2Apro in lanes 1
and 2 as indicated. Samples were separated on a 7.5% acrylamide gel (SDS-PAGE), transferred to a nitrocellulose membrane and probed with
an antiserum against eIF-4G. Intact eIF-4G as well as its amino-terminal (Nt) and carboxy-terminal (Ct) cleavage fragments are indicated.
B: E¡ect of di¡erent concentrations of MBP-2Apro on eIF-4G cleavage. The reaction was carried out as described above, except that the con-
centration of MBP-2Apro was varied. Hydrolysis of eIF-4G was estimated by densitometric quantitation of bands corresponding to intact
eIF-4G that remain after the incubations. The data are expressed as cleavage with respect to a control (incubation with MBP, 100% intactness
of eIF-4G) (O). RSW was used as source of eIF-4G.
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magnesium ions did not a¡ect the cleavage e⁄ciency of this
peptide.
4. Discussion
Taken together, the results presented here provide evidence
for a direct cleavage of eIF-4G by poliovirus 2Apro. In addi-
tion to previous ¢ndings on rhino- and coxsackievirus 2A
proteinases, direct interaction and subsequent cleavage of
eIF-4G by poliovirus 2Apro with eIF-4G can also be achieved
in vitro using the puri¢ed components. Furthermore, the use
of an eIF-4G-derived synthetic peptide suggests that poliovi-
rus 2Apro cleaves eIF-4G at Arg485-Gly486 bond. This is the
cleavage site within eIF-4G mapped for rhino- and cox-
sackievirus cognate 2Apro [19]. Therefore, 2A proteinases
from entero- and rhinoviruses appear to share the same
sequence speci¢city on eIF-4G.
Our data contrast in part with those reported by Wycko¡ et
al. [16] where cleavage of eIF-4G by poliovirus 2Apro was
observed only when additional factor(s) from HeLa cells
were present. This apparent discrepancy could be explained
by the use of di¡erent protocols to obtain recombinant polio-
virus 2Apro from E. coli and eIF-4F complexes from HeLa
cells. We have tested a highly puri¢ed and active form of
poliovirus 2Apro (MBP-2Apro) instead of the crude bacterial
extracts expressing 2Apro used by [16]. In addition, the eIF-4F
complex employed in the present work as substrate for MBP-
2Apro contains the eIF-4E factor. Recently, it has been re-
ported that this factor drasticaly increases the rate of cleavage
of eIF-4G by rhino- and coxsackievirus 2Apro and by aphtho-
virus Lpro [21,28]. We do not know if eIF-4G preparations
employed by Wycko¡ et al. [16] contained eIF-4E or not.
However, the lack of eIF-4E in such preparations could ex-
plain the dependence of 2Apro-mediated cleavage of eIF-4G
for eIF-3, that is usually contaminated with detectable
amounts of eIF-4G and eIF-4E when puri¢ed from HeLa cells
using the traditional protocols [6].
On the other hand, our data show that cleavage of eIF-4G
by poliovirus 2Apro is greatly dependent upon the ionic con-
ditions used. We believe that magnesium ions, more than to
serve as cofactor for MBP-2Apro, could serve to keep eIF-4G
under a proper conformation accessible to protease attack.
This is supported by the fact that when a synthetic peptide
was used as substrate instead of eIF-4G, no e¡ect of magne-
sium ions on cleavage was observed, most probably because
the cleavage site for MBP-2Apro is exposed in the short pep-
tide. Perhaps magnesium ions stabilize the eIF-4G-4E inter-
action, the most probable substrate for picornaviral 2Apro and
Lpro [21].
Note added in proof: When this manuscript was in progress we
learnt that Bovee et al. Virology 246, 241^249 (1998) have
reported results that agree with our present ¢ndings.
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